Page last updated: 24-JUN-2008
Female Genital Organ Cancers
Data analyses and reports
-
-
A
summary table of the main statistics for cancer of the female genital organs.
-
Cancer in Scotland Summary 
[264KB] is an overview of cancer in Scotland focusing on incidence, mortality and survival for the main cancer sites.
-
-
-
-
Cancer Research UK factsheets provide detailed analyses and interpretation of cancer data.
-
-
-
-
-
Data on the early detection of cervical cancer through screening:
PAF website (see section 2.04.02) and
cervical screening programme pages of this website.
-
Cancer of the cervix uteri: ICD-10 C53
| Incidence: |
Annual incidence [188KB] (1980 onwards) by age, sex, network and health board |
|
Five year summary of incidence[30KB] by age, sex, network and health board |
| Mortality: |
Annual mortality[181KB] (1980 onwards) by age, sex, network and health board |
|
Five year summary of mortality[30KB] by age, sex, network and health board |
| Survival: |
Survival[23KB] (by age and sex) at 1, 3, 5 & 10 years after diagnosis (1980 onwards) |
|
Survival summary [450KB] and interpretation at 1 & 5 years after diagnosis (1980 onwards) |
| Prevalence: |
Cancer prevalence[16KB] |
| Lifetime risk: |
Lifetime risk[16KB] of cancer by age and sex |
| Deprivation: |
Chart [17KB] of incidence, mortality and survival by deprivation category |
Carcinoma in situ of the cervix uteri: ICD-10 D06
Cancer of the corpus uteri: ICD-10 C54
| Incidence: |
Annual incidence[189KB] (1980 onwards) by age, sex, network and health board |
|
Five year summary of incidence[30KB] by age, sex, network and health board |
| Mortality: |
Annual mortality[182KB] (1980 onwards) by age, sex, network and health board |
|
Five year summary of mortality[30KB] by age, sex, network and health board |
| Survival: |
Survival[23KB] (by age and sex) at 1, 3, 5 & 10 years after diagnosis (1980 onwards) |
|
Survival summary [450KB] and interpretation at 1 & 5 years after diagnosis (1980 onwards) |
| Prevalence: |
Cancer prevalence[17KB] |
| Lifetime risk: |
Lifetime risk[16KB] of cancer by age and sex |
| Deprivation: |
Chart [16KB] of incidence, mortality and survival by deprivation category |
Ovarian cancer: ICD-10 C56
| Incidence: |
Annual incidence[187KB] (1980 onwards) by age, sex, network and health board |
|
Five year summary of incidence[30KB] by age, sex, network and health board |
| Mortality: |
Annual mortality[178KB] (1980 onwards) by age, sex, network and health board |
|
Five year summary of mortality[30KB] by age, sex, network and health board |
| Survival: |
Survival[23KB] (by age and sex) at 1, 3, 5 & 10 years after diagnosis (1980 onwards) |
|
Survival summary [450KB] and interpretation at 1 & 5 years after diagnosis (1980 onwards) |
| Prevalence: |
Cancer prevalence[16KB] |
| Lifetime risk: |
Lifetime risk[16KB] of cancer by age and sex |
| Deprivation: |
Chart [17KB] of incidence, mortality and survival by deprivation category |
Uterine cancer: ICD-10 C53-C55
Cancer of the vagina: ICD-10 C52
Cancer of the vulva: ICD-10 C51
Summary statistics for cancer of the female genital organs by cancer type
| Scotland |
Cancer type |
|
Cervix |
Corpus
uteri |
Ovary |
| Rank |
11 |
5 |
4 |
| Percentage frequency of all cancers |
2.1% |
3.9% |
4.4% |
| Number of new cases diagnosed in 2005 |
295 |
540 |
599 |
| Number of deaths recorded in 2006 |
92 |
104 |
400 |
| Change in incidence from 1995 to 2005 |
-29.0% |
+18.6% |
-6.8% |
| Change in mortality from 1996 to 2006 |
-33.2% |
+15.3% |
-8.4% |
| 1 year relative survival for patients diagnosed between 2000 and 2004 |
87.3% |
92.8% |
67.0% |
| 5 year relative survival for patients diagnosed between 2000 and 2004 |
68.5% |
82.9% |
38.1% |
Notes:
1. Recent changes in incidence of ovarian cancer may be caused to some extent by changes in classification. Cystadenomas of the ovary were coded as neoplasms of uncertain behaviour (ICD-9 236.2) until the introduction of ICD-10 and ICD-O-2 in 1997 and have been coded as malignant cancer (ICD-10 C56) since.
2. Survival figures are not age standardised.
3. Change in incidence and mortality is estimated by Poisson regression.
Cancer Stats
Printer friendly version
